YM155 as an inhibitor of cancer stemness simultaneously inhibits autophosphorylation of epidermal growth factor receptor and G9a-mediated stemness in lung cancer cells

Cancer stem cell survival is the leading factor for tumor recurrence after tumor-suppressive treatments. Therefore, specific and efficient inhibitors of cancer stemness must be discovered for reducing tumor recurrence. YM155 has been indicated to significantly reduce stemness-derived tumorsphere for...

Descripción completa

Detalles Bibliográficos
Autores principales: Cheng, Chun-Chia, Chang, Jungshan, Huang, Stanley Ching-Cheng, Lin, Huan-Chau, Ho, Ai-Sheng, Lim, Ken-Hong, Chang, Chun-Chao, Huang, Ling, Chang, Yu-Cheng, Chang, Yi-Fang, Wu, Cheng-Wen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5546577/
https://www.ncbi.nlm.nih.gov/pubmed/28787001
http://dx.doi.org/10.1371/journal.pone.0182149

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5546577/
https://www.ncbi.nlm.nih.gov/pubmed/28787001
http://dx.doi.org/10.1371/journal.pone.0182149

Ejemplares similares